Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-01-04 @ 2:56 AM
Study NCT ID:
NCT03298867
Status:
COMPLETED
Last Update Posted:
2024-07-11
First Post:
2017-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
Sponsor:
Amgen
Organization:
Conditions & Keywords Data
Conditions: